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ABSTRACT 
 
Some of derivatives containing oxadiazole and benzothiazole moieties 6(a-l) were synthesized and the structure of 
synthesized compounds was elucidated by IR, 
1
HNMR, 
13
C NMR and mass spectroscopy. This research article deals 
with newly synthesized benzothiazole containing oxadiazole derivatives that were assayed for investigation of their 
in vivo hypoglycemic activity by alloxan induced diabetic model in rat. All these derivatives showed significant 
biological efficacy when compared to a potent and well known antidiabetic agent (i.e. Glibenclamide). All the 
compounds were effective, amongst them 6f showed more prominent activity at 350 mg/kg p.o. The experimental 
results are statistically significant at p<0.01 and p<0.05 level.  
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Introduction 
Diabetes is one of metabolic disorders in the world 
characterized by persistent hyperglycemia with 
disturbances of carbohydrate, fat and protein 
metabolism resulting from defects in insulin secretion, 
insulin action or both. It is considered as one of the five 
leading causes of death in the world. The World Health 
Organization (WHO) estimates that more than 220 
million people worldwide have diabetes and this 
number is likely to more than double by 2030 (WHO, 
2009). Several drugs such as sulfonylurea and 
biguanides are presently available to reduce 
hyperglycemia in diabetes mellitus. These drugs have 
side effects and thus searching for a new class of 
compounds is crucial to overcome these problems. 
Heterocyclic compounds are the mainstay of 
antidiabetic therapy for many years [1].  
_______________________________ 
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In current years heterocyclic analogues and derivatives 
have attracted strong interest due to their biological and 
pharmacological properties. Benzothiazole is a 
heterocyclic compound, weak base, having varied 
biological activities and still of great scientific interest 
now a days. They are broadly found in bioorganic and 
medicinal chemistry with applications in drug 
discovery and development for the treatment of 
diabetes [2-3]. 2-mercaptobenzothiazole derivatives are 
known to possess various pharmacological activities 
[4]. Benzothiazole ring system is present in various 
marine and terrestrial natural compounds, which have 
useful biological activities[5].The benzthiazole 
derivatives has been play vital role in biological fields 
such as antitumor, antitubercular, antimalarial, 
anticonvulsant, anthelmintic, analgesic, anti-
inflammatory, antifungal, a topical carbonic anhydrase 
inhibitor and an antihypoxic. Benzothiazole derivatives 
containing benzimidazole and imidazoline ring have 
diverse chemical reactivity along with broad spectrum 
of biological activity which are valuable for its great 
pharmaceutical [6-8]. All these literatures deal with 
significant interest to synthesize the benzothiazole 
derivatives with an aim to obtain potent biologically 
active and safe anti diabetic agents. 
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Material and methods 
All the chemicals were of synthetic grade and 
commercially procured from Himedia Chemicals, 
Mumbai (Maharashtra) INDIA. Melting points were 
determined on a Tempo capillary melting point 
apparatus in open capillary tube and are uncorrected. 
All FTIR spectra were recorded (νmax in   cm-1) on 
Bruker Tensor 27 FT-IR spectrometer. 
1
H-NMR 
(proton nuclear magnetic resonance) spectrum were 
recorded at 300 MHz, after dissolving in a suitable 
solvent (DMSO,CDCl3 or D2O) on Bruker Avance II 
400 MHz, USA FT-NMR spectrometer using 
tetramethylsilane as internal standard and chemical 
shifts (δ) are reported in parts per million (ppm). 13C 
NMR was also recorded on Bruker Avance II FT-NMR 
spectrometer at frequency of 100 MHz. The spin 
multiplicities are indicated by symbols, s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet) and br 
(broad). Mass spectra were recorded on Waters UPLC-
TQD Mass spectrometer using electrospray ionization 
(ESI) technique. The purity of the compounds was 
ascertained by thin layer chromatography (TLC) and 
elemental analysis. Plates for TLC were prepared with 
silica gel G and activated at 110 
0
C for 30 min. Iodine 
vapors was used to develop the TLC plates. Elemental 
analyses were performed on a Vario EL-III analyzer. 
 
General Method of Synthesis for Benzthiazole Derivatives 
All the compounds were synthesized by using a synthetic route given in Fig 1:  
Table 1:  Benzothiazole derivatives with different substitutions 
S.NO. Compound Code R1 R2 R3 
1.  6a CH3 H C6H5- 
2.  6b CH3 H pNH2C6H4- 
3.  6c CH3 H pNO2C6H4- 
4.  6d CH3 H pOCH3C6H4- 
5.  6e NO2 H C6H5- 
6.  6f NO2 H pNH2C6H4- 
7.  6g NO2 H pNO2C6H4- 
8.  6h NO2 H pOCH3C6H4- 
9.  6i H NO2 C6H5- 
10.  6j H NO2 pNH2C6H4- 
11.  6k H NO2 pNO2C6H4- 
12.  6l H NO2 pOCH3C6H4- 
 
 
Fig 1: Scheme of Synthesis for Benzothiazole Derivatives 
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Synthesis of Substitutes Aniline Hydrochloride 
Salt [2]: The aniline (0.1mol) was taken in a round 
bottom flask and added a mixture of HCl (9ml) & 
water (25ml) .Then solution was heated for about 
30min and cool at room temp. Further, ammonium 
thiocyanate (0.1mol) was added to reaction mixture, 
refluxed for 4 hrs and cool it .The precipitate was 
filtered, washed with water, dried and crystallized from 
ethanol. 
 
Synthesis of Substituted 2-
Mercaptobenzothiazole [3]: A mixture of 
compound 2 ( 0.0025 mol), Potassium hydroxide 
(0.75gm) in water (6 ml) and carbon disulphide (1.6 
g, 0.01 mol) in presence of sulphur (5ml) and 
absolute ethanol (30 mL) at 280-2850c was heated 
under reflux for 2 h. and 600-700 psi pressure. The 
reaction mixture was cooled, filtered and the filtrate 
was acidified with dilute hydrochloric acid, the 
product formed was collected and recrystallized 
from ethanol [9]. 
Synthesis of Substituted ethyl 2-(benzo[d]thiazol-
2-ylthio)acetate[4]:2Mercaptobenzothiazole(0.2mol) 
and ethylchloroacetate (0.02 mol) in  dry acetone in the 
presence of K2CO3 (20g) was refluxed for 10 hr and 
the reaction mixture poured into ice and neutralized 
with dil.HCl, the solid thus obtained was washed 
several times with water and recrystallized from 
chloroform. 
 
Synthesis of Substituted 2-(benzo[d]thiazol-2-
ylthio)acetohydrazide [5]:In to a clean dry 100 mL 
round bottomed flask, the compound 4 (0.01 mol) was 
dissolved in ethanol (60 mL). The hydrazine hydrate 
(0.02 mol) (99%) was added drop by drop with 
constant stirring and the content were refluxed for 8 h, 
cooled to room temperature. 
  
Synthesis of Substituted 2-((benzo[d]thiazol-2-
ylthio)methyl)-5-phenyl-1,3,4-oxadiazole 
Derivatives [6a-l]:A mixture of compound 5 (1 g, 
0.01 mol) and different aryl acids (0.02 mol) in 
phosphoryl chloride (10 mL) was refluxed for 5 h. The 
resultant mixture was cooled to room temperature and 
poured into crushed ice with stirring. The solid thus 
obtained was filtered, washed with water and 
crystallized from ethanol to give compounds [10]. 
 
Determination of Physical Characteristic Properties 
of Synthesized Derivatives 
All physical characteristic properties were determined 
for all the synthesized derivatives that include 
molecular formula, molecular weight, melting point, 
percentage yield and Rf value. 
 
Pharmacological Evaluation of Synthesized 
Derivatives  
Determination of acute toxicity [11] 
The acute toxicity of synthesized benzothiazole 
derivatives were determined by using female albino 
rats (20–25 g) which were maintained under the 
standard conditions. The acclimatized animals (n= 5) 
were kept fasting with water ad libitum for 12 h prior 
to the experiment. The animals were administered with 
single dose of test compounds at a dose of 2000 mg/kg 
and observed for their mortality during 14 days period 
for toxicity study. The doses were increased up to 1000 
mg/kg and rats were observed up to 02 weeks for their 
behavioural, economical and neurological profiles 
except slight depression in their activity. No such 
signs, symptoms and mortality were observed even 
after 14 days. Hence the LD50 cut off value of the test 
compounds was fixed at 350 mg/kg and the same dose 
was considered for evaluation of anti diabetic activity. 
All the animal experiments were conducted by the 
approval of Institutional Animal Ethics Committee, 
Sapience Bio-analytical Laboratory Bhopal, Madhya 
Pradesh, India 
 
Assessments of anti-diabetic activity in alloxan-
induced diabetic rats [12] 
Induction of experimental diabetes by Alloxan 
monohydrate 
The fresh solution of Alloxan monohydrate in normal 
saline was administered p.o. into fasted rats at a dose of 
120 mg/kg body wt. After alloxan administration (i.p.), 
rats were given 5% (w/v) dextrose solution in feeding 
bottles for next 24 h in their cages to to prevent 
hypoglycaemia. The animals showing blood glucose 
range of 200-400 mg dL
-1
 were used for the experiment 
and the hyperglycemia was confirmed after 72 hours of 
Alloxan monohydrate administration (i.p.). The 
animals were also observed for consistent 
hyperglycaemia (fasting blood glucose) between 200-
400 mg/dl up to 14 days.  
Experimental Design 
Animals were divided into fifteen groups of 6 animals 
in each (n=6). Group 1 Non diabetic animals received 
normal saline solution as normal control group; Group 
2 diabetic animals received 1 ml of 0.5% carboxy 
methyl cellulose as positive diabetic control group; 
Group 3 diabetic animals received Glibenclamide 20 
mg/kg as standard group; Groups (4-15) diabetic 
animals received compounds 6a-6l in a single dose of 
350 mg/kg body weight p.o. respectively for 14 days 
continuously. 
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Blood Glucose Measurement 
Blood glucose level was monitored by tail dipping 
method. The blood sample was dropped on the 
dextrostrix reagent pad. The strip was inserted into 
microprocessor digital blood glucometer and reading 
ware noted. The blood glucose level was monitored at 
0 hr, 7hr, 14hr, 21hr respectively. 
Statistical Analysis 
The values were expressed as mean ± S.E.M. Data 
were analyzed using One-way ANOVA followed by 
Tukey-Kramer test. The values were considered to be 
significant at p<0.05 and p<0.01 level. 
Results  
 
All the benzthiazole derivatives 6(a-l) were synthesized 
by the given scheme and reaction process was 
monitored by thin layer chromatography method using 
silica gel-G stationary phase, ethyl acetate: chloform 
(2:1) as mobile phase, and detecting the spots with 
iodine vapors. All the physical constant data were 
characterized for all the synthesized derivatives that are 
given in the Table 2. 
 
Table 2: Physical Constant Data of Synthesized Derivatives 
 
           Properties        
Code of Derivatives 
Mol. Formula Mol. Wt. M.P.  in 
0
C % Yield Rf 
6a C17H13N3OS2 339.43 197-199 62.3 0.58 
6b C17H14N4OS2 354.45 214-216 72.5 0.62 
6c C17H12N4O3S2 384.43 203-205 75.9 0.74 
6d C18H15N3O2S2 369.46 265-268 66.8 0.69 
6e C16H10N4O3S2 370.41 187-189 68.8 0.65 
6f C16H11N5O3S2 385.42 208-210 79.1 0.71 
6g C16H9N5O5S2 415.40 190-192 83.2 0.81 
6h C17H12N4O4S2 400.43 231-233 73.7 0.78 
6i C16H10N4O3S2 370.41 166-168 58.4 0.61 
6j C16H11N5O3S2 385.42 183-185 64.7 0.67 
6k C16H9N5O5S2 415.40 173-175 71.2 0.77 
6l C17H12N4O4S2 400.43 220-225 60.9 0.71 
 
Experimental Data of Synthesized Derivatives 
 
(A) 2-(((6-methylbenzo[d]thiazol-2-yl)thio)methyl) 
-5-phenyl-1,3,4-oxadiazole[compound6a]:
Yield: 62.3 %; M.P. 197- 199 
0
C; Anal. Cal. for 
C17H13N3OS2: C, 60.15; H, 3.86; N, 12.38; O, 4.71; S, 
18.89 %; found: C, 60.18; H, 3.82; N, 12.36; O, 4.73; 
S, 18.90 %; FT-IR (νmax): 3058 (Aromatic C-H 
strech.), 2963(Asym. aliphatic C-H strech.), 2861 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1619 (C=N stretch.), 
1602 (Phenyl ring stretch.), 1512 (Phenyl C-H out of 
plane bending), 1467 (CH2 bending), 1458 (Asym CH3 
bending), 1392 (Sym. CH3 bending), 1278 (C-N 
Strech), 1154 (C-O stretch.), 758 & 712 (loop for mono 
substitution at phenyl ring), 694 (C-S stretch)  cm
-1
;
1
H-
NMR (CDCl3) (δ, ppm):  8.09-8.07 (d, 2H phenyl ring 
protons at C2 & C6), 7.89-7.87 (d, 1H benzthiazole ring 
proton at C8), 7.81 (s, 1H benzthiazole ring proton at 
C5), 7.55-7.51 (t, 2H phenyl ring protons at C3 & C5), 
7.42-7.40 (t, 1H phenyl ring proton at C4), 7.33-7.31 
(d, 1H benzthiazole ring proton at C7), 4.54 (s, 2H, 
SCH2- at oxadiazole ring), 2.34 (s, 3H, CH3 at 
benzthiazole ring);
13
C-NMR (CDCl3) (δ, ppm): 164.7 
(C2 carbon at benzthiazole ring), 164.5 (oxadiazole ring 
carbon at phenyl linkage), 163.2 (oxadiazole ring 
carbon at thiomethyl linkage),  150.4 (C9 carbon at 
benzthiazole ring), 135.2 (C4 carbon at benzthiazole 
ring), 134.2 (C6 carbon at benzthiazole ring), 129.2 (C3 
& C5 carbons at phenyl ring), 128.7 (C4 carbon at 
phenyl ring), 127.5 (C2 & C6 carbons at phenyl ring), 
126.6 (C7 carbon at benzthiazole ring), 121.5 (C8 
carbon at benzthiazole ring),122.9 (C1 carbon at phenyl 
ring), 121.3 (C5 carbon at benzthiazole ring), 34.8 (-
SCH2- carbon  at oxadiazole ring), 20.9 (methyl carbon 
at benzthiazole ring);  m/e (ESI): 339 (M
+
).                                                      
                                                                                      
(B) 4-(5-(((6-methylbenzo[d]thiazol-2-yl)thio) 
methyl)-1,3,4-oxadiazol-2-yl)aniline [compound  
6b]: 
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Yield: 72.5 %; M.P. 214- 216 
0
C; Anal. Cal. for 
C17H14N4OS2: C, 57.61; H, 3.98; N, 15.81; O, 4.51; S, 
18.09 %; found C, 57.63; H, 3.94; N, 15.79; O, 4.54; S, 
18.10%; FT-IR (νmax): 3412 (Asym. N-H strech.), 
3343(Sym. N-H strech.), 3045 (Aromatic C-H strech.), 
2959 (Asym. aliphatic C-H strech.), 2857 (Sym. 
aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1618 (C=N stretch.), 
1598 (Phenyl ring stretch.), 1509 (Phenyl C-H out of 
plane bending), 1465 (CH2 bending), 1456 (Asym CH3 
bending), 1390 (Sym. CH3 bending), 1275 (C-N 
Strech), 1158 (C-O stretch.), 868 (loop for di 
substitution at phenyl ring), 798 (out of plan N-H 
bending), 697 (C-S stretch)  cm
-1
; 
1
H-NMR (CDCl3) (δ, 
ppm):  7.89-7.87 (d, 1H benzthiazole ring proton at 
C8), 7.81 (s, 1H benzthiazole ring proton at C5), 7.54-
7.52 (d, 2H phenyl ring protons at C2 & C6), 7.33-7.31 
(d, 1H benzthiazole ring proton at C7), 7.60-7.58 (d, 2H 
phenyl ring protons at C3 & C5), 6.27 (s, 2H, Ph-NH2), 
4.54 (s, 2H, -SCH2- at oxadiazole ring), 2.34 (s, 3H, 
CH3 at benzthiazole ring); 
13
C-NMR (CDCl3) (δ, ppm): 
164.6 (C2 carbon at benzthiazole ring), 164.3 
(oxadiazole ring carbon at phenyl linkage), 163.4 
(oxadiazole ring carbon at thiomethyl linkage),  150.6 
(C9 carbon at benzthiazole ring), 145.6 (C4 carbon at 
phenyl ring), 135.7 (C4 carbon at benzthiazole ring), 
134.8 (C6 carbon at benzthiazole ring), 128.3 (C2 & C6 
carbons at phenyl ring), 126.9 (C7 carbon at 
benzthiazole ring), 121.9 (C8 carbon at benzthiazole 
ring), 121.6 (C5 carbon at benzthiazole ring), 116.7 (C1 
carbon at phenyl ring),  115.1 (C3 & C5 carbons at 
phenyl ring), 35.2 (-SCH2- carbon  at oxadiazole ring), 
21.3 (methyl carbon at benzthiazole ring); m/e (ESI): 
354 (M
+
).           
                                                                                                                                 
(C) 2-(((6-methylbenzo[d]thiazol-2-yl)thio) methyl) 
-5-(4-nitrophenyl)-1,3,4-oxadiazole [compound  6c]: 
Yield: 75.9 %; M.P. 203- 205 
0
C; Anal. Cal. for 
C17H12N4O3S2: C, 53.11; H, 3.15; N, 14.57; O, 12.49; 
S, 16.68 %; found: C, 53.13; H, 3.17; N, 14.53; O, 
12.51; S, 16.66 %; FT-IR (νmax): 3045 (Aromatic C-H 
strech.), 2959 (Asym. aliphatic C-H strech.), 2857 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1618 (C=N stretch.), 
1598 (Phenyl ring stretch.), 1552 (Asym. N=O 
stretch.), 1509 (Phenyl C-H out of plane bending), 
1465 (CH2 bending), 1456 (Asym CH3 bending), 1390 
(Sym. CH3 bending), 1349 (Sym. N=O stretch.), 1275 
(C-N Strech), 1158 (C-O stretch.), 872 (loop for di 
substitution at phenyl ring), 696 (C-S stretch)  cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm): 8.33-8.32 (d, 2H phenyl 
ring protons at C3 & C5), 7.25-7.23 (d, 2H phenyl ring 
protons at C2 & C6), 7.89-7.87 (d, 1H benzthiazole ring 
proton at C8), 7.81 (s, 1H benzthiazole ring proton at 
C5), 7.33-7.31 (d, 1H benzthiazole ring proton at C7), 
4.54 (s, 2H, -SCH2- at oxadiazole ring), 2.34 (s, 3H, 
CH3 at benzthiazole ring);  
13
C-NMR (CDCl3) (δ, ppm): 
164.5 (C2 carbon at benzthiazole ring), 164.3 
(oxadiazole ring carbon at phenyl linkage), 163.4 
(oxadiazole ring carbon at thiomethyl linkage), 150.4 
(C9 carbon at benzthiazole ring), 147.9 (C4 carbon at 
phenyl ring), 135.3 (C4 carbon at benzthiazole ring), 
134.5 (C6 carbon at benzthiazole ring), 132.2 (C1 
carbon at phenyl ring),  130.9 (C2 & C6 carbons at 
phenyl ring), 128.8 (C3 & C5 carbons at phenyl 
ring),126.6 (C7 carbon at benzthiazole ring), 121.5 (C8 
carbon at benzthiazole ring), 121.8 (C5 carbon at 
benzthiazole ring), 35.4 (-SCH2- carbon  at oxadiazole 
ring), 21.5 (methyl carbon at benzthiazole ring); m/e 
(ESI): 384 (M
+
).                                                                                                                                           
  
(D) 2-(4-methoxyphenyl)-5-(((6 methylbenzo [d] 
thiazol-2-yl)thio)methyl)-1,3,4-oxadiazole 
[compound  6d]: 
Yield: 66.8 %; M.P. 265-268 
0
C; Anal. Cal. for 
C18H15N3O2S2: C, 58.52; H, 4.09; N, 11.37; O, 8.66; S, 
17.36 %; found: C, 58.54; H, 4.11; N, 11.34; O, 8.68; 
S, 17.33 %; FT-IR (νmax): 3048 (Aromatic C-H 
strech.), 2962 (Asym. aliphatic C-H strech.), 2859 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1617 (C=N stretch.), 
1601 (Phenyl ring stretch.), 1511 (Phenyl C-H out of 
plane bending), 1467 (CH2 bending), 1459 (Asym CH3 
bending), 1388 (Sym. CH3 bending), 1277 (C-N 
Strech), 1246 (methoxy Asym. C-O strech), 1155 
(oxadiazole ring C-O stretch.), 1038 (methoxy sym. C-
O strech), 870 (loop for di substitution at phenyl ring), 
697 (C-S stretch) cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm): 
8.09-8.07 (d, 2H phenyl ring protons at C2 & C6), 7.89-
7.87 (d, 1H benzthiazole ring proton at C8), 7.81 (s, 1H 
benzthiazole ring proton at C5), 7.33-7.31 (d, 1H 
benzthiazole ring proton at C7), 7.06-7.05 (d, 2H 
phenyl ring protons at C3 & C5),4.54 (s, 2H, -SCH2- at 
oxadiazole ring), 3.83 (s, 3H, Ph-OCH3 ), 2.34 (s, 3H, 
CH3 at benzthiazole ring);
13
C-NMR (CDCl3) (δ, ppm): 
164.8 (C2 carbon at benzthiazole ring), 164.6 
(oxadiazole ring carbon at phenyl linkage), 163.4 
(oxadiazole ring carbon at thiomethyl linkage), 160.6 
(C4 carbon at phenyl ring), 150.9 (C9 carbon at 
benzthiazole ring), 135.4 (C4 carbon at benzthiazole 
ring), 134.3 (C6 carbon at benzthiazole ring), 126.6 (C7 
carbon at benzthiazole ring), 121.5 (C8 carbon at 
benzthiazole ring), 121.9 (C5 carbon at benzthiazole 
ring), 118.4 (C1 carbon at phenyl ring),  115.9 (C2 & C6 
carbons at phenyl ring), 114.8 (C3 & C5 carbons at 
phenyl ring), 55.8 (methoxy carbons at phenyl ring), 
35.4 (-SCH2- carbon  at oxadiazole ring), 21.5 (methyl 
carbon at benzthiazole ring); m/e (ESI): 369 (M
+
).     
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(E) 2-(((6-nitrobenzo[d]thiazol-2-yl)thio)methyl)-
5-phenyl-1,3,4-oxadiazole [compound 6e]: 
Yield: 68.8 %; M.P. 187- 189 
0
C; Anal. Cal. for 
C16H10N4O3S2: C, 51.88; H, 2.72; N, 15.13; O, 12.96; 
S, 17.31%; found: C, 51.86; H, 2.70; N, 15.16; O, 
12.98; S, 17.30%; FT-IR (νmax): 3061 (Aromatic C-H 
strech.), 2932(Asym. aliphatic C-H strech.), 2857 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1615 (C=N stretch.), 
1597 (Phenyl ring stretch.), 1548 (Asym. N=O 
stretch.), 1508 (Phenyl C-H out of plane bending), 
1466 (CH2 bending), 1353 (Sym. N=O stretch.), 1281 
(C-N Strech), 1158 (C-O stretch.), 754 & 714 (loop for 
mono substitution at phenyl ring), 696 (C-S stretch) 
cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm):  8.61 (s, 1H 
benzthiazole ring proton at C5), 8.32-8.30 (d, 1H 
benzthiazole ring proton at C7), 8.07-8.05 (d, 1H 
benzthiazole ring proton at C8), 8.02-8.00 (d, 2H 
phenyl ring protons at C2 & C6), 7.55-7.51 (t, 2H 
phenyl ring protons at C3 & C5), 7.44-7.42 (t, 1H 
phenyl ring proton at C4), 4.54 (s, 2H, -SCH2- at 
oxadiazole ring); 
13
C-NMR (CDCl3) (δ, ppm): 164.5 
(C2 carbon at benzthiazole ring), 164.3 (oxadiazole ring 
carbon at phenyl linkage), 163.1(oxadiazole ring 
carbon at thiomethyl linkage), 159.6 (C9 carbon at 
benzthiazole ring), 143.3 (C6 carbon at benzthiazole 
ring), 136.0 (C4 carbon at benzthiazole ring), 129.4 (C3 
& C5 carbons at phenyl ring), 128.5 (C4 carbon at 
phenyl ring), 127.7 (C2 & C6 carbons at phenyl ring), 
122.8 (C1 carbon at phenyl ring), 122.4 (C8 carbon at 
benzthiazole ring), 121.3 (C7 carbon at benzthiazole 
ring), 119.1 (C5 carbon at benzthiazole ring), 34.6 (-
SCH2- carbon  at oxadiazole ring); m/e (ESI): 370 (M
+
).   
                                                                                                                                         
(F) 4-(5-(((6-methylbenzo[d]thiazol-2-yl)thio) 
methyl)-1,3,4-oxadiazol-2-yl)aniline [compound  6f]: 
Yield: 79.1 %; M.P. 208- 210 
0
C; Anal. Cal. for 
C16H11N5O3S2: C, 49.86; H, 2.88; N, 18.17; O, 12.45; 
S, 16.64 %; found: C, 49.89; H, 2.84; N, 18.19; O, 
12.43; S, 16.61 %; FT-IR (νmax): 3415 (Asym. N-H 
strech.), 3346(Sym. N-H strech.), 3048 (Aromatic C-H 
strech.), 2929 (Asym. aliphatic C-H strech.), 2856 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1617 (C=N stretch.), 
1601 (Phenyl ring stretch.), 1513 (Phenyl C-H out of 
plane bending), 1467 (CH2 bending), 1277 (C-N 
Strech), 1162 (C-O stretch.), 872 (loop for di 
substitution at phenyl ring), 802 (out of plan N-H 
bending), 695 (C-S stretch)  cm
-1
; 
1
H-NMR (CDCl3) (δ, 
ppm):  8.62 (s, 1H benzthiazole ring proton at C5), 
8.32-8.30 (d, 1H benzthiazole ring proton at C7), 8.01-
8.00 (d, 1H benzthiazole ring proton at C8), 7.54-7.52 
(d, 2H phenyl ring protons at C2 & C6), 6.57-6.55 (d, 
2H phenyl ring protons at C3 & C5), 6.27 (s, 2H, Ph-
NH2), 4.55 (s, 2H, -SCH2- at oxadiazole ring); 
13
C-
NMR (CDCl3) (δ, ppm): 164.6 (C2 carbon at 
benzthiazole ring), 164.3 (oxadiazole ring carbon at 
phenyl linkage), 163.2 (oxadiazole ring carbon at 
thiomethyl linkage), 159.4(C9 carbon at benzthiazole 
ring), 145.4 (C4 carbon at phenyl ring), 143.5 (C6 
carbon at benzthiazole ring), 136.2 (C4 carbon at 
benzthiazole ring), 128.5 (C2 & C6 carbons at phenyl 
ring), 122.6 (C8 carbon at benzthiazole ring), 121.5 (C7 
carbon at benzthiazole ring), 119.3 (C5 carbon at 
benzthiazole ring), 116.3 (C1 carbon at phenyl ring), 
115.3 (C3 & C5 carbons at phenyl ring), 34.7 (-SCH2- 
carbon  at oxadiazole ring); m/e (ESI): 385 (M
+
).                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
(G) 2-(((6-nitrobenzo[d]thiazol-2-yl)thio) meth 
yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole [compound  
6g]: 
Yield: 83.2 %; M.P. 190- 192 
0
C; Anal. Cal. for 
C16H9N5O5S2: C, 46.26; H, 2.18; N, 16.86; O, 19.26; S, 
15.44 %; found: C, 46.24; H, 2.14; N, 16.89; O, 19.28; 
S, 15.45 %; FT-IR (νmax): 3049 (Aromatic C-H 
strech.), 2929 (Asym. aliphatic C-H strech.), 2861 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1617 (C=N stretch.), 
1602 (Phenyl ring stretch.), 1548 (Asym. N=O 
stretch.), 1510 (Phenyl C-H out of plane bending), 
1468 (CH2 bending), 1354 (Sym. N=O stretch.), 1279 
(C-N Strech), 1156 (C-O stretch.), 876 (loop for di 
substitution at phenyl ring), 694 (C-S stretch) cm
-1
; 
1
H-
NMR (CDCl3) (δ, ppm):  8.62 (s, 1H benzthiazole ring 
proton at C5), 8.38-8.36 (d, 2H phenyl ring protons at 
C3 & C5), 8.32-8.30 (d, 1H benzthiazole ring proton at 
C7), 8.24-8.22 (d, 2H phenyl ring protons at C2 & C6), 
8.01-8.00 (d, 1H benzthiazole ring proton at C8), 4.55 
(s, 2H, -SCH2- at oxadiazole ring); 
13
C-NMR (CDCl3) 
(δ, ppm): 164.8 (C2 carbon at benzthiazole ring), 164.6 
(oxadiazole ring carbon at phenyl linkage), 163.5 
(oxadiazole ring carbon at thiomethyl linkage), 
159.6(C9 carbon at benzthiazole ring), 147.7 (C4 carbon 
at phenyl ring), 143.7 (C6 carbon at benzthiazole ring), 
136.5 (C4 carbon at benzthiazole ring), 132.4 (C1 
carbon at phenyl ring), 130.6 (C2 & C6 carbons at 
phenyl ring), 128.5 (C3 & C5 carbons at phenyl ring), 
122.9 (C8 carbon at benzthiazole ring), 121.7 (C7 
carbon at benzthiazole ring), 119.6 (C5 carbon at 
benzthiazole ring), 34.9 (-SCH2- carbon  at oxadiazole 
ring); m/e (ESI): 415 (M
+
).                                                                                                                                           
 
(H) 2-(4-methoxyphenyl)-5-(((6-nitrobenzo [d]thia 
zol-2-yl)thio)methyl)-1,3,4-oxadiazole[compound 
6h]:Yield: 73.7 %; M.P. 231-233 
0
C; Anal. Cal. for 
C17H12N4O4S2: C, 50.99; H, 3.02; N, 13.99; O, 15.98; 
S, 16.02 %; found: C, 51.02; H, 3.01; N, 13.94; O, 
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16.00; S, 16.03 %; FT-IR (νmax): 3055 (Aromatic C-H 
strech.), 2958 (Asym. aliphatic C-H strech.), 2864 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1615 (C=N stretch.), 
1603 (Phenyl ring stretch.), 1552(Asym. N=O stretch.), 
1514 (Phenyl C-H out of plane bending), 1469 (CH2 
bending), 1457 (Asym CH3 bending), 1386 (Sym. CH3 
bending), 1354 (Sym. N=O stretch.), 1275 (C-N 
Strech), 1249 (methoxy Asym. C-O strech), 1158 
(oxadiazole ring C-O stretch.), 1039 (methoxy sym. C-
O strech), 873 (loop for di substitution at phenyl ring), 
695 (C-S stretch) cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm):  
8.62 (s, 1H benzthiazole ring proton at C5), 8.32-8.30 
(d, 1H benzthiazole ring proton at C7), 8.04-8.02 (d, 2H 
phenyl ring protons at C2 & C6), 8.01-8.00 (d, 1H 
benzthiazole ring proton at C8), 7.03-7.01 (d, 2H 
phenyl ring protons at C3 & C5), 4.55 (s, 2H, -SCH2- at 
oxadiazole ring), 3.85 (s, 3H, Ph-OCH3); 
13
C-NMR 
(CDCl3) (δ, ppm): 164.5 (C2 carbon at benzthiazole 
ring), 164.4 (oxadiazole ring carbon at phenyl linkage), 
163.3 (oxadiazole ring carbon at thiomethyl linkage), 
160.8 (C4 carbon at phenyl ring), 159.3(C9 carbon at 
benzthiazole ring), 143.4 (C6 carbon at benzthiazole 
ring), 136.2 (C4 carbon at benzthiazole ring), 122.7 (C8 
carbon at benzthiazole ring), 121.5 (C7 carbon at 
benzthiazole ring), 119.9 (C5 carbon at benzthiazole 
ring), 118.3 (C1 carbon at phenyl ring), 115.6 (C2 & C6 
carbons at phenyl ring), 114.5 (C3 & C5 carbons at 
phenyl ring), 34.6 (-SCH2- carbon  at oxadiazole ring); 
m/e (ESI): 400 (M
+
). 
 
(I) 2-(((5-nitrobenzo[d]thiazol-2-yl)thio)methyl)-
5-phenyl-1,3,4-oxadiazole [compound  6i]: Yield: 
58.4 %; M.P. 166- 168 
0
C; Anal. Cal. for 
C16H10N4O3S2: C, 51.88; H, 2.72; N, 15.13; O, 12.96; 
S, 17.31 %; found: C, 51.90; H, 2.68; N, 15.11; O, 
12.98; S, 17.33 %; FT-IR (νmax): 3064 (Aromatic C-H 
strech.), 2935(Asym. aliphatic C-H strech.), 2859 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring), 1617 (C=N stretch.), 
1599 (Phenyl ring stretch.), 1546 (Asym. N=O 
stretch.), 1510 (Phenyl C-H out of plane bending), 
1468 (CH2 bending), 1357 (Sym. N=O stretch.), 1277 
(C-N Strech), 1155 (C-O stretch.), 757 & 717 (loop for 
mono substitution at phenyl ring), 698 (C-S stretch) 
cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm):  9.16 (s, 1H 
benzthiazole ring proton at C8), 8.32-8.30 (d, 1H 
benzthiazole ring proton at C6), 8.27-8.25 (d, 1H 
benzthiazole ring proton at C5), 8.04-8.02 (d, 2H 
phenyl ring protons at C2 & C6), 7.54-7.51 (t, 2H 
phenyl ring protons at C3 & C5), 7.42-7.40 (t, 1H 
phenyl ring proton at C4), 4.53 (s, 2H, -SCH2- at 
oxadiazole ring); 
13
C-NMR (CDCl3) (δ, ppm): 164.6 
(C2 carbon at benzthiazole ring), 164.2 (oxadiazole ring 
carbon at phenyl linkage), 163.3(oxadiazole ring 
carbon at thiomethyl linkage), 154.4 (C9 carbon at 
benzthiazole ring), 146.3 (C7 carbon at benzthiazole 
ring), 141.1 (C4 carbon at benzthiazole ring), 129.6 (C3 
& C5 carbons at phenyl ring), 128.3 (C4 carbon at 
phenyl ring), 127.4 (C2 & C6 carbons at phenyl ring), 
122.9 (C1 carbon at phenyl ring), 122.4 (C5 carbon at 
benzthiazole ring), 119.3 (C6 carbon at benzthiazole 
ring), 117.4 (C8 carbon at benzthiazole ring), 34.7 (-
SCH2- carbon  at oxadiazole ring); m/e (ESI): 370 (M
+
).                                 
                                                                                                           
(J) 4-(5-(((5-nitrobenzo[d]thiazol-2-yl)thio)methyl 
)-1,3,4-oxadiazol-2-yl)aniline [compound  6j]: 
Yield: 64.7 %; M.P. 183-85 
0
C; Anal. Cal. for 
C16H11N5O3S2: C, 49.86; H, 2.88; N, 18.17; O, 12.45; 
S, 16.64 %; found: C, 49.88; H, 2.85; N, 18.15; O, 
12.47; S, 16.65%; FT-IR (νmax): 3418 (Asym. N-H 
strech.), 3348 (Sym. N-H strech.), 3053 (Aromatic C-H 
strech.), 2933 (Asym. aliphatic C-H strech.), 2858 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1615 (C=N stretch.), 
1603 (Phenyl ring stretch.), 1511 (Phenyl C-H out of 
plane bending), 1465 (CH2 bending), 1279 (C-N 
Strech), 1164 (C-O stretch.), 874 (loop for di 
substitution at phenyl ring), 798 (out of plan N-H 
bending), 697 (C-S stretch)  cm
-1
; 
1
H-NMR (CDCl3) (δ, 
ppm):  9.16 (s, 1H benzthiazole ring proton at C8), 
8.32-8.30 (d, 1H benzthiazole ring proton at C6), 8.27-
8.25 (d, 1H benzthiazole ring proton at C5), 7.54-7.52 
(d, 2H phenyl ring protons at C2 & C6), 6.55-6.54 (d, 
2H phenyl ring protons at C3 & C5), 6.28 (s, 2H, Ph-
NH2), 4.53 (s, 2H, -SCH2- at oxadiazole ring); 
13
C-
NMR (CDCl3) (δ, ppm): 164.7 (C2 carbon at 
benzthiazole ring), 164.3 (oxadiazole ring carbon at 
phenyl linkage), 163.5(oxadiazole ring carbon at 
thiomethyl linkage), 154.6 (C9 carbon at benzthiazole 
ring), 146.5 (C7 carbon at benzthiazole ring), 145.5 (C4 
carbon at phenyl ring), 141.3 (C4 carbon at 
benzthiazole ring), 128.6 (C2 & C6 carbons at phenyl 
ring), 122.6 (C5 carbon at benzthiazole ring), 119.5 (C6 
carbon at benzthiazole ring), 117.6 (C8 carbon at 
benzthiazole ring), 116.4 (C1 carbon at phenyl ring), 
115.4 (C3 & C5 carbons at phenyl ring), 34.5 (-SCH2- 
carbon  at oxadiazole ring); m/e (ESI): 385 (M
+
).                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
(K)  2-(((5-nitrobenzo[d]thiazol-2-yl)thio)methyl)-
5-(4-nitrophenyl)-1,3,4-oxadiazole [compound  6k]: 
Yield: 71.2 %; M.P. 173- 175 
0
C; Anal. Cal. for 
C16H9N5O5S2: C, 46.26; H, 2.18; N, 16.86; O, 19.26; S, 
15.44  %; found: C, 46.29; H, 2.15; N, 16.82; O, 19.29; 
S, 15.45 %; FT-IR (νmax): 3053 (Aromatic C-H 
strech.), 2933 (Asym. aliphatic C-H strech.), 2858 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1616 (C=N stretch.), 
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1604 (Phenyl ring stretch.), 1553 (Asym. N=O 
stretch.), 1512 (Phenyl C-H out of plane bending), 
1466 (CH2 bending), 1356 (Sym. N=O stretch.), 1276 
(C-N Strech), 1154 (C-O stretch.), 874 (loop for di 
substitution at phenyl ring), 696 (C-S stretch) cm
-1
; 
1
H-
NMR (CDCl3) (δ, ppm):  9.15 (s, 1H benzthiazole ring 
proton at C8), 8.38-8.36 (d, 2H phenyl ring protons at 
C3 & C5), 8.32-8.30 (d, 1H benzthiazole ring proton at 
C6), 8.26-8.24 (d, 1H benzthiazole ring proton at C5),
 
8.23-8.21 (d, 2H phenyl ring protons at C2 & C6), 4.55 
(s, 2H, -SCH2- at oxadiazole ring); 
13
C-NMR (CDCl3) 
(δ, ppm): 164.8 (C2 carbon at benzthiazole ring), 164.6 
(oxadiazole ring carbon at phenyl linkage), 
163.6(oxadiazole ring carbon at thiomethyl linkage), 
154.7 (C9 carbon at benzthiazole ring), 146.6 (C7 
carbon at benzthiazole ring), 147.8 (C4 carbon at 
phenyl ring), 141.5 (C4 carbon at benzthiazole ring), 
132.5 (C1 carbon at phenyl ring), 130.7 (C2 & C6 
carbons at phenyl ring), 128.6 (C3 & C5 carbons at 
phenyl ring), 122.7 (C5 carbon at benzthiazole ring), 
119.6 (C6 carbon at benzthiazole ring), 117.8 (C8 
carbon at benzthiazole ring), 34.5 (-SCH2- carbon  at 
oxadiazole ring); m/e (ESI): 415 (M
+
).                                                                                                                                           
 
(L) 2-(4-methoxyphenyl)-5-(((5-nitrobenzo[d] thia 
zol-2-yl)thio)methyl)-1,3,4-oxadiazole [compound  
6l]:Yield: 60.9 %; M.P. 220- 225 
0
C; Anal. Cal. for 
C17H12N4O4S2: C, 50.99; H, 3.02; N, 13.99; O, 15.98; 
S, 16.02 %; found: C, 50.97; H, 3.03; N, 13.97; O, 
16.00; S, 16.03%; FT-IR (νmax): 3058 (Aromatic C-H 
strech.), 2963 (Asym. aliphatic C-H strech.), 2859 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1617 (C=N stretch.), 
1601 (Phenyl ring stretch.), 1549 (Asym. N=O 
stretch.), 1512 (Phenyl C-H out of plane bending), 
1466 (CH2 bending), 1459 (Asym CH3 bending), 1388 
(Sym. CH3 bending), 1357 (Sym. N=O stretch.), 1278 
(C-N Strech), 1247 (methoxy Asym. C-O strech), 1156 
(oxadiazole ring C-O stretch.), 1037 (methoxy sym. C-
O strech), 876 (loop for di substitution at phenyl ring), 
698 (C-S stretch) cm
-1
; 
1
H-NMR (CDCl3) (δ, ppm) 
9.17 (s, 1H benzthiazole ring proton at C8), 8.32-8.30 
(d, 1H benzthiazole ring proton at C6), 8.25-8.22 (d, 1H 
benzthiazole ring proton at C5),  8.01-8.00 (d, 2H 
phenyl ring protons at C2 & C6), 7.03-7.01 (d, 2H 
phenyl ring protons at C3 & C5), 4.55 (s, 2H, -SCH2- at 
oxadiazole ring), 3.84 (s, 3H, Ph-OCH3); 
13
C-NMR 
(CDCl3) (δ, ppm): 164.4 (C2 carbon at benzthiazole 
ring), 164.1 (oxadiazole ring carbon at phenyl linkage), 
163.5(oxadiazole ring carbon at thiomethyl linkage), 
160.3 (C4 carbon at phenyl ring), 154.6 (C9 carbon at 
benzthiazole ring), 146.7 (C7 carbon at benzthiazole 
ring), 141.4 (C4 carbon at benzthiazole ring), 122.7 (C5 
carbon at benzthiazole ring), 119.6 (C6 carbon at 
benzthiazole ring), 118.7 (C1 carbon at phenyl ring), 
117.5 (C8 carbon at benzthiazole ring), 115.5 (C2 & C6 
carbons at phenyl ring), 114.6 (C3 & C5 carbons at 
phenyl ring), 55.6 (methoxy carbons at phenyl ring), 
34.6 (-SCH2- carbon  at oxadiazole ring); m/e (ESI): 
400 (M
+
).  
 
Evaluation of anti-diabetic activity in alloxan-
induced diabetic rats  
The LD50 values of the synthesized compounds were 
estimated to be in the range of 300-2000 mg/kg b.w. 
Alloxan induces diabetes through rapid depletion of β-
cells which ultimately results to reduce the insulin 
release. The antidiabetic activity of synthesized 
compounds 6(a-l) on diabetic rats were reported in 
Table 3. 
 
Table 3:Antidiabetic activity of synthesized compounds 6(a-l) on diabetic rats 
S. No.  
Treatment 
 
Blood Glucose Level (mg/dl) % Reduction in B.G. 
0
th
  day 7
th
 day 14
th
 day 21
st
 day  
1.  Normal Control 105.09±
1.2 
102±0.3 102±0.9 100±1.2 - 
2.  Diabetic Positive control 274±1.3 273±1.6 271±1.4 270±1.9 - 
3.  Glibenclamide 10 mg/kg 311±2.1 239±2.4 178±1.8 103±1.7 66.88 % 
 Each Test Group receives 350 mg/kg (p.o.) as effective dose. 
4.  6a  288±3.4 263±2.2 195±0.5 186±3.2 35.40% 
5.  6b 305±1.4 272±2.8 226±1.3 178±2.3 41.63% 
6.  6c 272±1.7 273±3.2 199±1.6 170±2.9 37.05% 
7.  6d 270±1.9 259±2.7 208±1.9 179±1.5 33.70% 
8.  6e 366±4.2 255±2.7 205±1.5 135±2.6 63.11% 
9.  6f 365±3.6 334±3.4 208±2.2 121±1.8 66.84% 
10.  6g 398±1.3 262±2.5 204±1.4 140±3.1 64.82% 
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11.  6h 303±1.5 259±2.5 198±1.1 129±1.8 57.42% 
12.  6i 298±2.7 253±3.1 202±0.8 154±3.3 48.32% 
13.  6j 307±1.6 254±2.6 199±2.2 142±2.4 53.74% 
14.  6k 317±2.8 286±2.3 227±1.9 159±2.1 49.84% 
15.  6l 299±2.8 255±2.9 202±1.3 162±4.1 46.91% 
 
Discussion 
 
All the synthesized derivatives were also confirmed by 
FTIR, 
1
H NMR, C
13
NMR and mass spectroscopy 
method. The FTIR spectrums were shown the 
significant peaks at 3060-3045 (Aromatic C-H strech.), 
2970-2960 (Asym. aliphatic C-H strech.), 2865-2855 
(Sym. aliphatic C-H strech.), 1665- 2000 (overtone for 
substitution on aromatic ring ), 1610-1620 (C=N 
stretch.), 1605-1595 (Phenyl ring stretch.), 1520-1505 
(Phenyl C-H out of plane bending), 1470-1465 (CH2 
bending), 1460-1455 (Asym CH3 bending), 1395-1385 
(Sym. CH3 bending), 1280-1270 (C-N Strech), 1160-
1150 (C-O stretch.), 880-870 (loop for di substitution 
at phenyl ring), 695-685 (C-S stretch)  cm
-1
. The 
different substitutions on phenyl ring were confirmed 
through FTIR spectrum peaks at 3450-3350 cm
-1 
(N-H 
stretch.) for amino group, 1250 (Asym. C-O strech.) & 
1040 (Sym. C-O stretch.) for methoxy group, 1550 
(Asym. N=O stretch.) & 1350 (Sym. N=O streching) 
for nitro group substitution. The proton NMR 
spectrums were also confirmed the different 
substitutions on phenyl as well as benzothiazole ring 
through significant signals due to change in 
environment of protons. Similarly the environment 
surrounding carbon atoms were also changed through 
different substitutions which were confirmed through 
the C
13
NMR. The mass spectroscopy studies were 
confirmed the molecular weight of derivatives through 
molecular ion peak on mass spectrum (i.e. peak at 
highest m/e). . All the results of antidiabetic activity of 
synthesized compounds 6(a-l) on diabetic rats 
summarized in Table 3 revealed that most of the 
synthesized compounds exhibited antidiabetic response 
at the end of twenty first day of experimental period. It 
has been found that oral administration of synthesized 
compounds 6e, 6f, 6g, 6h and 6j caused a more 
significant reduction in blood glucose than other 
compounds in diabetic rats. However, the compound 6f 
at 350 mg/kg b.w. exerted maximum glucose lowering 
effects whereas 6d showed minimum glucose lowering 
effects. The maximum glucose lowering effects of 
compound 6i may be due to the presence of 
heterocyclic amine (morpholine). 
Conclusion 
All the newly oxadiazole containing benzothiazole 
derivatives were synthesized by sequencing scheme 
and confirmed by different spectroscopy methods. The 
physicochemical properties were characterized and 
evaluated their anti diabetic activity for all synthesized 
derivatives in alloxan induced diabetic rat model. 
Amongst all these synthesized derivatives compound 
6g shown more potent anti diabetic activity at 350 
mg/kg p.o. 
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